Monoclonal Antibody to N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP)
| Code | Size | Price |
|---|
| MAA485Hu29-20ul | 20ul | £90.00 |
Quantity:
| MAA485Hu29-100ul | 100ul | £170.00 |
Quantity:
| MAA485Hu29-200ul | 200ul | £230.00 |
Quantity:
| MAA485Hu29-1ml | 1ml | £528.00 |
Quantity:
Prices exclude any Taxes / VAT
Overview
Host Type: Mouse
Antibody Clonality: Monoclonal
Regulatory Status: RUO
Applications:
- Immunocytochemistry (ICC)
- Immunohistochemistry (IHC)
- Immunoprecipitation (IP)
- Western Blot (WB)
Documents
Further Information
Alternative Names:
NT-Pro-BNP; ; N-BNP
Buffer Formulation:
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Ig Isotype:
IgG2b Kappa
Immunogen:
CPA485Hu21-OVA Conjugated N-Terminal Pro-Brain Natriuretic Peptide (NT-ProBNP)
Item Name:
N-Terminal Pro-Brain Natriuretic Peptide
Potency (Clone Number):
C8
Reactivity:
Po;
Source:
Monoclonal antibody preparation
Subcategory:
Monoclonal antibody preparation
USAGE:
Western blotting: 0.5-2ug/mL;
Immunohistochemistry: 5-20ug/mL;
Immunocytochemistry: 5-20ug/mL;
Optimal working dilutions must be determined by end user.
Immunohistochemistry: 5-20ug/mL;
Immunocytochemistry: 5-20ug/mL;
Optimal working dilutions must be determined by end user.
Related Products
| Product Name | Product Code | Supplier | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Immunogen | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| OVA Conjugated N-Terminal Pro-Brain Natriuretic Peptide (NTroBNP) | CPA485Hu21 | Cloud-Clone Corp. | Summary Details | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||